Piper Jaffray Merchant Banking
Piper Sandler Merchant Banking is the growth equity investment arm of Piper Sandler Companies (NYSE: PIPR), a publicly traded Minneapolis-based investment bank founded in 1895. The division invests growth capital in healthcare and technology companies and operates within a six-line full-service investment banking platform ranked No. 1 by U.S. bank M&A deal count for 13 consecutive years.
- Company typePublic
- Founded1895
- HeadquartersMinneapolis, United States
- Headcount—
- GTM typeB2B
- OfferingServices
What Piper Jaffray Merchant Banking does
Piper Sandler Merchant Banking is the growth equity investment and alternative asset management division of Piper Sandler Companies (NYSE: PIPR), a publicly traded full-service investment bank headquartered in Minneapolis. The firm traces its origins to 1895 with the founding of Piper Jaffray and adopted its current name following the 2020 merger with Sandler O'Neill + Partners (founded 1998). Piper Sandler Merchant Banking makes direct growth equity investments in healthcare and technology companies, typically leading or co-investing in Series C and later-stage rounds; recent investments include an $85 million lead investment in CereVasc's Series C (June 2026) alongside J&J Innovation–JJDC, Medtronic, and Bain Capital Life Sciences, and a strategic growth investment in Kandu, Inc. (January 2026) alongside K2 HealthVentures.
The broader Piper Sandler platform operates six core service lines: Investment Banking (M&A advisory, IPO and follow-on underwriting, debt placements), Public Finance (senior underwriting of municipal negotiated U.S. transactions), Research (equity research across multiple sectors), Fixed Income (sales, trading, market-making for institutional clients), Equities (capital markets and trading), and Alternative Asset Management (which encompasses the Merchant Banking division). Revenue is generated through transaction-based advisory and underwriting fees, fixed income trading spreads, research subscriptions, asset management fees, and equity returns from merchant banking investments. Pricing is quote-based and varies by deal size and complexity, with no publicly disclosed standard rate card.
The firm serves mid-to-large corporate clients, federal/state/local government entities, financial sponsors (PE, VC), and sector-specific verticals including Healthcare, Technology, Energy/Power/Infrastructure, Consumer, Financial Services, and Government. Distribution is relationship-based through sector-focused investment banking teams, supplemented by industry conferences (Government & Defense Technology CEO Summit, Annual Macro Conference, Growth Frontiers Conference), thought-leadership content via the News & Insights blog, and earned media. Piper Sandler is ranked No. 1 Bank M&A advisor by number of deals for 13 consecutive years (S&P Global Market Intelligence), No. 2 Advisor in U.S. M&A for announced deals under $2B (Mergermarket), senior underwriter of municipal negotiated U.S. transactions (LSEG), and No. 1 Financial advisor in U.S. for energy services M&A (internal database and Bloomberg league tables as of September 2025).
Piper Jaffray Merchant Banking firmographics
Firmographics- Name
- Piper Jaffray Merchant Banking
- Legal name
- Piper Sandler Companies
- Website
- https://piperjaffray.com
- Company type
- Public
- Founded year
- 1895
- Operating status
- Operating
- Short description
- Piper Sandler Merchant Banking is the growth equity investment arm of Piper Sandler Companies (NYSE: PIPR), a publicly traded Minneapolis-based investment bank founded in 1895. The division invests growth capital in healthcare and technology companies and operates within a six-line full-service investment banking platform ranked No. 1 by U.S. bank M&A deal count for 13 consecutive years.
- Ownership category
- akta.pro rank
Piper Jaffray Merchant Banking industry classification
Industry- Product category
- Merchant Banking and Private Equity
- NAICS
- Investment Banking and Securities Intermediation (52315)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Debt Capital Raising Intermediation (Private Debt/Mezzanine/Bonds) (FSAEALAM)
Keywords
Where Piper Jaffray Merchant Banking is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Markets served
Piper Jaffray Merchant Banking business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Investment Banking Advisory: M&A advisory fees, underwriting fees, and placement agent commissions for debt and equity offerings. Services include financial advisory on mergers and acquisitions, capital markets transactions including IPOs, follow-on offerings, and debt placements. Revenue is transaction-based with fees typically structured as a percentage of deal value.
- Public Finance: Senior underwriter of municipal negotiated U.S. transactions. Provides underwriting services for government and municipal bond offerings, with revenue earned through underwriting spreads on bond issuances.
- Merchant Banking / Private Equity: Piper Sandler Merchant Banking makes direct equity investments in growth-stage companies, particularly in healthcare and technology sectors. Returns generated through equity ownership, with exits via IPOs, acquisitions, or secondary sales. Participates in Series C and growth financing rounds as a lead or co-investor.
- Alternative Asset Management: Fixed income and equities trading for institutional clients, research services, and management fees from alternative investment products. Revenue includes trading spreads, research subscription fees, and asset management charges.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Transaction-based investment banking fees |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Piper Jaffray Merchant Banking product offering
Product offeringCore offering
Piper Jaffray Merchant Banking (now Piper Sandler Merchant Banking) is the alternative asset management and private equity arm of Piper Sandler Companies. It makes direct equity investments in growth-stage companies, primarily in healthcare and technology sectors, participating as a lead or co-investor in Series C and growth financing rounds. The division generates returns through equity ownership with exits via IPOs, acquisitions, or secondary sales.
Product overview
Piper Sandler operates as a diversified investment bank offering six core service lines: Investment Banking, Public Finance, Research, Fixed Income, Alternative Asset Management, and Equities. The Alternative Asset Management division includes Merchant Banking services that provide growth capital investments to healthcare and technology companies. Piper Sandler is ranked No. 2 in U.S. M&A for announced deals under $2B and No. 1 by number of deals for 13 consecutive years.
Differentiator
Problem solved
Functional benefit
Products and services
- Growth Equity Investments
Quantifiable outcome
- No. 1 Bank M&A advisor by number of deals for 13 consecutive years
- +1 more outcomes
Companies that use Piper Jaffray Merchant Banking
Customer profileSegments5 records
Ideal customer profiles2 records
Piper Jaffray Merchant Banking technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Piper Jaffray Merchant Banking partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights4 records
Piper Jaffray Merchant Banking competitors and assessment
Company assessmentDirect peers
- Bain Capital Life Sciences: Healthcare-focused growth equity and venture platform that co-invested alongside PJMB in CereVasc's $85M Series C. Highly comparable given shared focus on late-stage healthcare growth equity and similar check sizes.
- OrbiMed: One of the largest healthcare-dedicated investment firms globally, making growth equity and venture investments across medical devices, biotech, and healthtech—directly comparable to PJMB's healthcare growth equity thesis.
- SV Health Investors: Healthcare-focused growth equity and venture firm investing across therapeutics, medical devices, and digital health. Highly comparable investment mandate and stage focus to PJMB's merchant banking activities.
- Perceptive Xontogeny Venture Funds: Healthcare-focused venture and growth equity fund that co-invested with PJMB in CereVasc's Series C. Comparable as a healthcare growth equity co-investor with similar check sizes and stage preferences.
- KKR Health Care Strategic Growth: Growth equity platform within KKR focused on healthcare and life sciences. Direct competitor for healthcare growth-stage deals with much larger AUM scale but similar thesis.
- EQT Life Sciences: Healthcare-dedicated growth equity and venture franchise within EQT, focused on medical devices, therapeutics, and digital health. Direct competitor for healthcare growth equity deals comparable to PJMB.
- New Enterprise Associates: Large multi-stage venture and growth equity firm with a substantial healthcare franchise. Comparable as a growth-stage investor with healthcare specialization and similar Series C check sizes.
Broad incumbents
- Goldman Sachs Merchant Banking Division: Private equity arm of Goldman Sachs making healthcare and growth equity investments. Comparable as a merchant banking division within a larger investment bank, though at materially larger scale and broader sector mandate.
- Morgan Stanley Capital Partners: Middle-market private equity arm of Morgan Stanley Investment Management. Comparable as a merchant banking franchise within a diversified investment bank, though more generalist than PJMB's healthcare focus.
Emerging players
- TPG Capital: Large alternative asset manager with a dedicated healthcare growth strategy (TPG Capital Healthcare). Comparable as a scaled healthcare growth equity investor that increasingly competes for the same deal flow as PJMB.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Piper Jaffray Merchant Banking social profiles
Digital presencePiper Jaffray Merchant Banking financial estimates
Financial estimateRevenue estimate
Valuation estimate
Piper Jaffray Merchant Banking leadership team
Management profileNumber of profiles
Profiles2 records
Piper Jaffray Merchant Banking funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Piper Jaffray Merchant Banking M&A and investment
M&A and investmentM&A
Investments11 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Piper Jaffray Merchant Banking
What does Piper Jaffray Merchant Banking do?
Piper Jaffray Merchant Banking (now Piper Sandler Merchant Banking) is the alternative asset management and private equity arm of Piper Sandler Companies. It makes direct equity investments in growth-stage companies, primarily in healthcare and technology sectors, participating as a lead or co-investor in Series C and growth financing rounds. The division generates returns through equity ownership with exits via IPOs, acquisitions, or secondary sales.
Is Piper Jaffray Merchant Banking a public or private company?
Piper Jaffray Merchant Banking is a public company. It is classified as corporate owned and is currently operating.
When was Piper Jaffray Merchant Banking founded?
Piper Jaffray Merchant Banking was founded in 1895.
Where is Piper Jaffray Merchant Banking based?
Piper Jaffray Merchant Banking is headquartered in Minneapolis, United States, in the North America region.
How does Piper Jaffray Merchant Banking make money?
Four revenue lines are on record. Investment Banking Advisory is the primary driver. The others are public Finance, merchant Banking / Private Equity and alternative Asset Management.
Who are Piper Jaffray Merchant Banking's main competitors?
Direct peers on record are Bain Capital Life Sciences, OrbiMed, SV Health Investors, Perceptive Xontogeny Venture Funds, KKR Health Care Strategic Growth, EQT Life Sciences and New Enterprise Associates. Broad incumbents are Goldman Sachs Merchant Banking Division and Morgan Stanley Capital Partners. TPG Capital is listed as an emerging player.
Does Piper Jaffray Merchant Banking have an API?
No public API is recorded for Piper Jaffray Merchant Banking.
What industry is Piper Jaffray Merchant Banking in?
Piper Jaffray Merchant Banking's product category is Merchant Banking and Private Equity. Its primary akta.pro industry code is FSAEALAM, Debt Capital Raising Intermediation (Private Debt/Mezzanine/Bonds). Its NAICS code is 52315 and its SIC code is 6211.